CYP2A6 Antibodies

Santa Cruz Biotechnology provides a broad selection of CYP2A6 monoclonal antibodies for research focused on understanding this important enzyme. CYP2A6 Antibodies are validated for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP2A6 is a member of the cytochrome P450 family and plays a crucial role in the metabolism of various substances, including drugs and carcinogens. Its activity is significant in pharmacogenomics, as variations in CYP2A6 can influence individual responses to medications and susceptibility to certain diseases. Understanding the function of CYP2A6 is essential for advancing personalized medicine and improving therapeutic outcomes. Research involving CYP2A6 has revealed its importance in metabolizing numerous compounds, making it a key focus in drug development studies. Investigating CYP2A6 expression patterns and activity levels can provide critical information about drug metabolism variations among different populations. The role of CYP2A6 in various metabolic pathways continues to be an active area of research, with new findings emerging regularly. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of CYP2A6, contributing to breakthroughs in drug metabolism research and therapeutic development.